Genentech 2021-02: Pharmacokinetics and Dose Response/Fractionation of GDC-5780 in the murine lung infection model with select enterobacteriaceae isolates

Project Details

StatusFinished
Effective start/end date13/07/21 → 12/07/22

Funding

  • Genentech: $132,530.87